Cargando…

Olfactory Dysfunction in Mental Illness

PURPOSE OF REVIEW: Olfactory dysfunction contributes to the psychopathology of mental illness. In this review, we describe the neurobiology of olfaction, and the most common olfactory alterations in several mental illnesses. We also highlight the role, hitherto underestimated, that the olfactory pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marin, Concepció, Alobid, Isam, Fuentes, Mireya, López-Chacón, Mauricio, Mullol, Joaquim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875195/ https://www.ncbi.nlm.nih.gov/pubmed/36696016 http://dx.doi.org/10.1007/s11882-023-01068-z

Ejemplares similares

Olfactory dysfunction during COVID-19 pandemic()
por: Izquierdo-Domínguez, Adriana, et al.
Publicado: (2020)

Reply
por: Mullol, Joaquim, et al.
Publicado: (2020)

Olfactory Dysfunction in a Mexican Population Outside of COVID-19 Pandemic: Prevalence and Associated Factors (the OLFAMEX Study)
por: Castillo-López, Irma Yolanda, et al.
Publicado: (2020)

Effect of Lipopolysaccharide on Glucocorticoid Receptor Function in Control Nasal Mucosa Fibroblasts and in Fibroblasts from Patients with Chronic Rhinosinusitis with Nasal Polyps and Asthma
por: Fernández-Bertolín, Laura, et al.
Publicado: (2015)

The Loss of Smell and Taste in the COVID-19 Outbreak: a Tale of Many Countries
por: Mullol, Joaquim, et al.
Publicado: (2020)

Furthering the understanding of olfaction, prevalence of loss of smell and risk factors: a population-based survey (OLFACAT study)
por: Mullol, Joaquim, et al.
Publicado: (2012)

Reconstituted Human Upper Airway Epithelium as 3-D In Vitro Model for Nasal Polyposis
por: de Borja Callejas, Francisco, et al.
Publicado: (2014)

Overuse of diagnostic tools and medications in acute rhinosinusitis in Spain: a population-based study (the PROSINUS study)
por: Jaume, Francesca, et al.
Publicado: (2018)

Superior effect of MP‐AzeFlu compared to monotherapy with fluticasone propionate or azelastine on GILZ, MKP‐1 and TTP anti‐inflammatory gene expression in healthy and inflamed upper airway mucosa
por: Vicens‐Artés, Sònia, et al.
Publicado: (2022)

Effect of MP‐AzeFlu compared to monotherapy on COX‐2, PGE(2), and EP2 gene expression in upper airway mucosa
por: Vicens‐Artes, Sonia, et al.
Publicado: (2022)

Pérdida del sentido del olfato durante la pandemia COVID-19
por: Izquierdo-Domínguez, Adriana, et al.
Publicado: (2020)

Management of Mechanical Nasal Obstruction Isolated or Associated to Upper Airway Inflammatory Diseases in Real Life: Use of both Subjective and Objective Criteria
por: Merma-Linares, Carla, et al.
Publicado: (2023)

Chronic Rhinosinusitis and COVID-19
por: Marin, Concepció, et al.
Publicado: (2022)

Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers
por: Roca-Ferrer, Jordi, et al.
Publicado: (2018)

Chemosensory dysfunction in COVID-19 out-patients
por: Rojas-Lechuga, María Jesús, et al.
Publicado: (2020)

551 The Impact of Nasal Polyposis on Quality of Life Using the Eq-5d Health Profile
por: Alobid, Isam, et al.
Publicado: (2012)

133 Corticosteroid Rreatment Reduces Tissue Eosinophilia and the Expression of Matrix Metalloproteinases (MMP-1, MMP-2, MMP-7, MMP-9) and Their Tissue Inhibitor (TIMP-1) in Nasal Polyps
por: de Borja Callejas, Fco, et al.
Publicado: (2012)

Signal Transduction Pathways (MAPKs, NF-κB, and C/EBP) Regulating COX-2 Expression in Nasal Fibroblasts from Asthma Patients with Aspirin Intolerance
por: Garcia-Garcia, Francesc Josep, et al.
Publicado: (2012)

Consensus on the management of united airways disease with type 2 inflammation: a multidisciplinary Delphi study
por: Blanco-Aparicio, Marina, et al.
Publicado: (2023)

Mometasone and desloratadine additive effect on eosinophil survival and cytokine secretion from epithelial cells
por: Mullol, Joaquim, et al.
Publicado: (2011)

Pathophysiology of SARS-CoV-2 Infection of Nasal Respiratory and Olfactory Epithelia and Its Clinical Impact
por: Chee, Jeremy, et al.
Publicado: (2023)

Archetype of Olfactory and Gustatory Dysfunction in Breakthrough COVID-19 Illness
por: Sagar, Prem, et al.
Publicado: (2021)

Self-reported Taste and Smell Disorders in Patients with COVID-19: Distinct Features in China
por: Song, Jia, et al.
Publicado: (2021)

Diagnostic tools in Rhinology EAACI position paper
por: Scadding, Glenis, et al.
Publicado: (2011)

MP29-02* reduces eosinophil survival induced by epithelial cell secretions from nasal mucosa
por: Roca-Ferrer, Jordi, et al.
Publicado: (2015)

Gustatory and olfactory dysfunctions in hospitalised patients with COVID-19 pneumonia: a prospective study
por: Inciarte, Alexy, et al.
Publicado: (2021)

Management of Anterior Skull Base Defect Depending on Its Size and Location
por: Bernal-Sprekelsen, Manuel, et al.
Publicado: (2014)

Chemosensory Dysfunction in Patients with COVID-19: What Do We Learn from the Global Outbreak?
por: Zeng, Ming, et al.
Publicado: (2021)

Effects of Olfactory Training in Patients With Postinfectious Olfactory Dysfunction
por: Choi, Bo Yoon, et al.
Publicado: (2021)

Management of Allergic Diseases During COVID-19 Outbreak
por: Izquierdo-Domínguez, Adriana, et al.
Publicado: (2021)

Olfactory dysfunction and COVID-19
por: Choi, Rhea, et al.
Publicado: (2022)

Comparative Analysis of Olfactory and Gustatory Function of Patients With COVID-19 Olfactory Dysfunction and Non-COVID-19 Postinfectious Olfactory Dysfunction
por: Jung, Taesik, et al.
Publicado: (2023)

Olfactory dysfunction revisited: a reappraisal of work-related olfactory dysfunction caused by chemicals
por: Werner, Sabine, et al.
Publicado: (2018)

Individual variability of olfactory fMRI in normosmia and olfactory dysfunction
por: Yunpeng, Zang, et al.
Publicado: (2020)

Mutational Spectrum, Ocular and Olfactory Phenotypes of CNGB1-Related RP-Olfactory Dysfunction Syndrome in a Multiethnic Cohort
por: Geada, Sara, et al.
Publicado: (2023)

Olfactory dysfunction in Alzheimer’s disease
por: Zou, Yong-ming, et al.
Publicado: (2016)

Factors that modulate olfactory dysfunction
por: Beecher, Kate, et al.
Publicado: (2018)

Olfactory dysfunction and COVID-19
por: Wan, Yi-Min, et al.
Publicado: (2020)

Therapies for Olfactory Dysfunction — an Update
por: Jafari, Aria, et al.
Publicado: (2022)

Olfactory Dysfunction in Huntington’s Disease
por: Patino, Jorge, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k2am51jjvsa1p7g92j4v3r9hfe